Claudia Caserini

1.1k total citations
15 papers, 919 citations indexed

About

Claudia Caserini is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Claudia Caserini has authored 15 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Claudia Caserini's work include Cancer-related Molecular Pathways (7 papers), Cancer therapeutics and mechanisms (5 papers) and Metal complexes synthesis and properties (5 papers). Claudia Caserini is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Cancer therapeutics and mechanisms (5 papers) and Metal complexes synthesis and properties (5 papers). Claudia Caserini collaborates with scholars based in Italy and United States. Claudia Caserini's co-authors include Paola Perego, Rosanna Supino, Sabina Carla Righetti, Franco Zunino, John C. Reed, Domenico Delia, Toshiyuki Miyashita, Marco A. Pierotti, Monica Giarola and Silvano Spinelli and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, British Journal of Cancer and Cell Death and Differentiation.

In The Last Decade

Claudia Caserini

15 papers receiving 897 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudia Caserini Italy 13 578 570 179 90 79 15 919
Franco Zunino Italy 17 765 1.3× 618 1.1× 273 1.5× 101 1.1× 102 1.3× 30 1.3k
F. Zunino Italy 19 514 0.9× 565 1.0× 119 0.7× 123 1.4× 116 1.5× 33 1.2k
Donatella Polizzi Italy 14 465 0.8× 383 0.7× 174 1.0× 67 0.7× 37 0.5× 17 774
H.H. Fiebig Germany 16 440 0.8× 387 0.7× 273 1.5× 92 1.0× 70 0.9× 41 883
Suzanne Leijen Netherlands 13 728 1.3× 770 1.4× 227 1.3× 98 1.1× 80 1.0× 19 1.3k
Yasuhide Hirota Japan 13 766 1.3× 1.1k 1.9× 197 1.1× 119 1.3× 58 0.7× 21 1.5k
Lynn M. Pouliot United States 5 338 0.6× 566 1.0× 121 0.7× 237 2.6× 81 1.0× 5 893
Andrew McGown United Kingdom 11 228 0.4× 325 0.6× 107 0.6× 111 1.2× 51 0.6× 28 661
Nicola Dobbs United Kingdom 15 378 0.7× 367 0.6× 118 0.7× 122 1.4× 65 0.8× 26 899

Countries citing papers authored by Claudia Caserini

Since Specialization
Citations

This map shows the geographic impact of Claudia Caserini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Caserini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Caserini more than expected).

Fields of papers citing papers by Claudia Caserini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Caserini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Caserini. The network helps show where Claudia Caserini may publish in the future.

Co-authorship network of co-authors of Claudia Caserini

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Caserini. A scholar is included among the top collaborators of Claudia Caserini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Caserini. Claudia Caserini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Gatti, Laura, Rosanna Supino, Paola Perego, et al.. (2002). Apoptosis and growth arrest induced by platinum compounds in U2-OS cells reflect a specific DNA damage recognition associated with a different p53-mediated response. Cell Death and Differentiation. 9(12). 1352–1359. 39 indexed citations
2.
Supino, Rosanna, Paola Perego, Laura Gatti, et al.. (2001). A role for c-myc in DNA damage-induced apoptosis in a human TP53-mutant small-cell lung cancer cell line. European Journal of Cancer. 37(17). 2247–2256. 22 indexed citations
3.
Supino, Rosanna, Maria Grazia Bottone, C. Pellicciari, et al.. (2001). Sinusoidal 50 Hz magnetic fields do not affect structural morphology and proliferation of human cells in vitro.. PubMed. 16(3). 719–26. 12 indexed citations
4.
Arcamone, Federico, Fabio Animati, Mario Bigioni, et al.. (1999). Configurational requirements of the sugar moiety for the pharmacological activity of anthracycline disaccharides. Biochemical Pharmacology. 57(10). 1133–1139. 25 indexed citations
5.
Perego, Paola, Laura Gatti, Claudia Caserini, et al.. (1999). The cellular basis of the efficacy of the trinuclear platinum complex BBR 3464 against cisplatin-resistant cells. Journal of Inorganic Biochemistry. 77(1-2). 59–64. 61 indexed citations
6.
Pratesi, Graziella, Paola Perego, Donatella Polizzi, et al.. (1999). A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts. British Journal of Cancer. 80(12). 1912–1919. 105 indexed citations
7.
Perego, Paola, Claudia Caserini, Laura Gatti, et al.. (1999). A Novel Trinuclear Platinum Complex Overcomes Cisplatin Resistance in an Osteosarcoma Cell System. Molecular Pharmacology. 55(3). 528–534. 105 indexed citations
8.
Pratesi, Graziella, Michelandrea De Cesare, Claudia Caserini, et al.. (1998). Improved efficacy and enlarged spectrum of activity of a novel anthracycline disaccharide analogue of doxorubicin against human tumor xenografts.. PubMed. 4(11). 2833–9. 30 indexed citations
9.
Arcamone, F, Fabio Animati, Mario Bigioni, et al.. (1997). Doxorubicin Disaccharide Analogue: Apoptosis-Related Improvement of Efficacy In Vivo. JNCI Journal of the National Cancer Institute. 89(16). 1217–1223. 54 indexed citations
10.
Perego, Paola, Sabina Carla Righetti, Rosanna Supino, et al.. (1997). Role of apoptosis and apoptosis-related proteins in the cisplatin-resistant phenotype of human tumor cell lines. APOPTOSIS. 2(6). 540–548. 46 indexed citations
11.
Caserini, Claudia, Graziella Pratesi, Monica Tortoreto, et al.. (1997). Apoptosis as a determinant of tumor sensitivity to topotecan in human ovarian tumors: preclinical in vitro/in vivo studies.. PubMed. 3(6). 955–61. 23 indexed citations
12.
Supino, Rosanna, Claudia Caserini, L. Orlandi, et al.. (1996). Modulation of melphalan cytotoxic activity in human melanoma cell lines. Anti-Cancer Drugs. 7(5). 604–612. 3 indexed citations
13.
Marchesini, Renato, Ambrogio Colombo, Claudia Caserini, et al.. (1996). Interaction of ionizing radiation with topotecan in two human tumor cell lines. International Journal of Cancer. 66(3). 342–346. 43 indexed citations
14.
Animati, Fabio, F Arcamone, Mario Bigioni, et al.. (1996). Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.. Molecular Pharmacology. 50(3). 603–609. 12 indexed citations
15.
Perego, Paola, Monica Giarola, Sabina Carla Righetti, et al.. (1996). Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.. PubMed. 56(3). 556–62. 339 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026